NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Solve FSHD

Solve FSHD

Vancouver, British Columbiasolvefshd.com

Overview

Solve FSHD is a venture philanthropic organization that makes strategic investments in academic, biotech, and biopharmaceutical organizations to accelerate the development of therapies for Facioscapulohumeral muscular dystrophy (FSHD).

Year Founded

2022

Portfolio Companies

6

Investments

Solve FSHD investments
CompanyDateStageLead
Ani BiomeMay 2025GrantCo-investor
Armatus BioMay 2025VC RoundLead
Epicrispr BiotechnologiesMar 2025Series B-
Altay TherapeuticsJul 2023GrantCo-investor
Vita TherapeuticsOct 2022Series BLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersVancouver, British Columbia
Year Founded2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.